AJP - Renal AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (June 11, 2008). doi:10.1152/ajprenal.00018.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/2/F415    most recent
00018.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ardura, J. A.
Right arrow Articles by Esbrit, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ardura, J. A.
Right arrow Articles by Esbrit, P.
Submitted on January 11, 2008
Accepted on June 9, 2008

Parathyroid hormone-related protein interacts with vascular endothelial growth factor to promote fibrogenesis in the obstructed mouse kidney

Juan Antonio Ardura1, Raul Berruguete1, David Ramila1, M.Victoria Alvarez-Arroyo2, and Pedro Esbrit1*

1 Bone and Mineral Metabolism Laboratory, Fundacion Jimenez Diaz, Madrid, Spain
2 Bone and Mineral Metabolism Laboratory , Fundacion Jimenez Diaz, Spain; Laboratorio de Metabolismo Renovascular, Fundacion Jimenez Diaz, Spain

* To whom correspondence should be addressed. E-mail: pesbrit{at}fjd.es.

Parathyroid hormone-related protein (PTHrP) interacts with vascular endothelial growth factor (VEGF) in osteoblasts. Since both PTHrP and VEGF have both pro-inflammatory and pro-fibrogenic features, we assessed here whether these factors might act in concert to promote fibrogenesis in the obstructed kidney. VEGF receptor (VEGFR)-1 was upregulated, while VEGFR-2 was downregulated (at both mRNA and protein levels) in the mouse kidney within 2-6 days after ureteral obstruction. VEGF protein levels also increased in the obstructed kidney at the latter time. Moreover, this VEGF and VEGFR-1 up-regulation was higher in mice overexpressing PTHrP in the proximal tubule than in control littermates. These changes were associated with higher fibronectin mRNA expression and {alpha}-smooth muscle actin ({alpha}-SMA) and integrin-linked kinase (ILK) immunostaining and lower apoptotic tubulointerstitial cells in the mouse obstructed kidney than in control littermates. Pre-treatment with a neutralizing anti-VEGF antibody reversed these responses in the obstructed kidney of both types of mice. In vitro, PTHrP (1-36) increased (maximal 2-fold vs basal, at 100 nM) {alpha}-SMA and ILK protein expression and decreased E-cadherin protein levels in renal tubuloepithelial MCT and NRK 52E cells. PTHrP (1-36) also decreased cyclosporine A- and/or osmotic stress-induced apoptosis in these cells and in renal fibroblastic NRK 49F cells. These effects elicited by PTHrP (1-36) were associated with both VEGF and VEGFR-1 upregulation, and abolished by the anti-VEGF antibody. Collectively, these findings strongly suggest that VEGF acts as an important mediator of PTHrP to promote fibrogenesis in the obstructed kidney.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.